Preoperative Epoetin-α with Intravenous or Oral Iron for Major Orthopedic Surgery
Autor: | Thibault Loupec, Xavier Capdevila, Sophie Bringuier, Pierre Smilevitch, Gaëtan Dangelser, Philippe Biboulet, Caroline Thuile, Mathieu Pencole, Guillaume Maissiat |
---|---|
Rok vydání: | 2018 |
Předmět: |
medicine.medical_specialty
Nausea business.industry 030204 cardiovascular system & hematology Preoperative care Gastroenterology law.invention 03 medical and health sciences 0302 clinical medicine Anesthesiology and Pain Medicine Randomized controlled trial 030202 anesthesiology Interquartile range Erythropoietin law Internal medicine medicine Clinical endpoint Hemoglobin medicine.symptom Prospective cohort study business medicine.drug |
Zdroj: | Anesthesiology. 129:710-720 |
ISSN: | 0003-3022 |
Popis: | Editor’s Perspective What We Already Know about This Topic What This Article Tells Us That Is New Background Preoperative administration of epoetin-α with iron is commonly used in anemic patients undergoing major orthopedic surgery, but the optimal route of iron intake is controversial. The aim of this study was to compare the clinical effects of erythropoietin in combination with oral or intravenous iron supplementation. Methods This study was a prospective, randomized, single-blinded, parallel arm trial. Patients scheduled for elective hip or knee arthroplasty with hemoglobin 10 to 13 g/dl received preoperative injections of erythropoietin with oral ferrous sulfate or intravenous ferric carboxymaltose. The primary endpoint was the hemoglobin value the day before surgery. Results One hundred patients were included in the analysis. The day before surgery, hemoglobin, increase in hemoglobin, and serum ferritin level were higher in the intravenous group. For the intravenous and oral groups, respectively, hemoglobin was as follows: median, 14.9 g/dl (interquartile range, 14.1 to 15.6) versus 13.9 g/dl (interquartile range, 13.2 to 15.1), group difference, 0.65 g/dl (95% CI, 0.1 to 1.2; P = 0.017); increase in hemoglobin: 2.6 g/dl (interquartile range, 2.1 to 3.2) versus 1.9 g/dl (interquartile range, 1.4 to 2.5), group difference, 0.7 g/dl (95% CI, 0.3 to 1.1; P < 0.001); serum ferritin: 325 µg/l (interquartile range, 217 to 476) versus 64.5 µg/l (interquartile range, 44 to 107), group difference, 257 µg/l (95% CI, 199 to 315; P < 0.001). The percentage of patients with nausea, diarrhea, or constipation was higher in the oral group, 52% versus 2%; group difference, 50% (95% CI, 35 to 64%; P < 0.0001). Conclusions After preoperative administration of erythropoietin, body iron stores and stimulation of the erythropoiesis were greater with intravenous ferric carboxymaltose than with oral ferrous sulfate supplementation. |
Databáze: | OpenAIRE |
Externí odkaz: |